These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10691008)

  • 1. A successful pregnancy in a heterozygote for OTC deficiency treated with sodium phenylbutyrate.
    Redonnet-Vernhet I; Rouanet F; Pedespan JM; Hocke C; Parrot F
    Neurology; 2000 Feb; 54(4):1008. PubMed ID: 10691008
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium phenylbutyrate for urea cycle enzyme deficiencies.
    Med Lett Drugs Ther; 1996 Nov; 38(988):105-6. PubMed ID: 8941257
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment of girls with ornithine transcarbamylase deficiency.
    Maestri NE; Brusilow SW; Clissold DB; Bassett SS
    N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic counseling in ornithine carbamoyltransferase deficiency].
    Pelet A; Toumas E; Rabier D; Kaplan J; Kamoun P; Frezal J; Saudubray JM; Munnich A
    Ann Biol Clin (Paris); 1988; 46(7):455-9. PubMed ID: 2903704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
    Scaglia F; Carter S; O'Brien WE; Lee B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of DNA analysis in a family with OTC deficiency.
    McClead RE; Rozen R; Fox J; Rosenberg L; Menke J; Bickers R; Morrow G
    Am J Med Genet; 1986 Nov; 25(3):513-8. PubMed ID: 2878615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
    Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
    Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
    Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
    N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site specific screening for point mutations in ornithine transcarbamylase deficiency.
    Feldmann D; Rozet JM; Pelet A; Hentzen D; Briand P; Hubert P; Largilliere C; Rabier D; Farriaux JP; Munnich A
    J Med Genet; 1992 Jul; 29(7):471-5. PubMed ID: 1353535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of severe OTC deficiency.
    Brubakk AM; Teijema LL; Blom W; Berger R
    J Pediatr; 1982 Jun; 100(6):929-31. PubMed ID: 7086593
    [No Abstract]   [Full Text] [Related]  

  • 12. Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency.
    Matsuura T; Hoshide R; Kiwaki K; Komaki S; Koike E; Endo F; Oyanagi K; Suzuki Y; Kato I; Ishikawa K
    Hum Mutat; 1994; 3(4):402-6. PubMed ID: 8081398
    [No Abstract]   [Full Text] [Related]  

  • 13. [Familial primary ornithine carbamoyltransferase defect].
    Wettstein A; Colombo JP
    Med Klin (Munich); 1986 Nov; 81(23):767-70. PubMed ID: 3807826
    [No Abstract]   [Full Text] [Related]  

  • 14. Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous females.
    Oppliger Leibundgut E; Liechti-Gallati S; Colombo JP; Wermuth B
    Hum Mutat; 1997; 9(5):409-11. PubMed ID: 9143919
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal counseling in heterozygotes for ornithine transcarbamylase deficiency.
    Fries MH; Kuller JA; Jurecki E; Packman S
    Clin Pediatr (Phila); 1994 Sep; 33(9):525-9. PubMed ID: 8001320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase].
    Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM
    Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of ornithine carbamoyl transferase deficiency using a gene specific probe.
    Pembrey ME; Old JM; Leonard JV; Rodeck CH; Warren R; Davies KE
    J Med Genet; 1985 Dec; 22(6):462-5. PubMed ID: 3001312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
    Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
    Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense mutation in the exon containing the putative ornithine-binding domain of the OTC enzyme in a female.
    Demmer LA; Kim JM; de Martinville B; Dowton SB
    Hum Mutat; 1996; 7(3):279. PubMed ID: 8829665
    [No Abstract]   [Full Text] [Related]  

  • 20. Carrier detection of urea cycle disorders.
    Ng WG; Oizumi J; Koch R; Shaw KN; McLaren J; Donnel GN; Carter M
    Pediatrics; 1981 Sep; 68(3):448-52. PubMed ID: 7279481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.